Odyssey Therapeutics, Inc.
NASDAQ:ODTXBiotechnology
Healthcare
$18.98 -0.05%
-$0.01 today
- Market cap
- $912.33M
- Beta
- 0.00
52W Low $15.35High $20.30
Volume 0.37M
Average 0.43M
ODTX Total Debt
Short-term and long-term borrowings combined.
No reported Total Debt figures are available to summarize.
Total Debt history
Currency unavailable · from the balance sheet
No Total Debt data reported for this period type.
Total Debt vs competitors
How ODTX compares with its peers on the latest reported figures
ODTX Competitors
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Mar 2026 | $277.36M USD | +1680.8% | -10.1% | 84.1% | |
ALMSAlumis Inc. Common Stock | Jun 2026 | $36.43M USD | -6.1% | +174.8% | 6.5% |
| Jun 2026 | $9.22M USD | -18.3% | +41.3% | 1.0% | |
ORKAOruka Therapeutics, Inc. | Sep 2026 | $2.93M USD | +53.3% | +71.5% | 0.2% |
| Mar 2026 | $1.99M USD | -20.1% | +45.7% | 1.0% | |
AGMBAgomAb Therapeutics N.V. American Depositary Shares | Sep 2025 | €1.33M EUR | — | — | 0.8% |
| Mar 2026 | $421K USD | -56.8% | -24.1% | 0.2% | |
| Sep 2026 | $0 USD | — | — | 0.0% | |
ODTXOdyssey Therapeutics, Inc. | — | — | — | — | — |
| Peer median (excluding ODTX) | — | -12.2% | +43.5% | 0.9% | |
Competitors are the stored peer set for ODTX. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Currency unavailable
Odyssey Therapeutics, Inc.
NASDAQ:ODTX
Intrinsic Alpha fair value
Locked
Current Price
$18.98
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.